Introduction
Overexpression of a tyrosine kinase is a common genetic defect in a variety of human tumors (Biscardi et al., 1999) . We demonstrated previously that 3Y1 rat ®broblasts overexpressing c-Src become transformed when treated with tumor-promoting phorbal esters (Lu et al., , 1998 . This eect is similar to a model for cooperating oncogenes proposed by Weinberg and colleagues where the transformation of primary cells required two cooperating oncogenes such as Ras and Myc (Land et al., 1983; Hahn et al., 1999) . Ras also cooperated with phorbol esters to transform primary cells (Dotto et al., 1985) . However, expression of Myc alone resulted in apoptosis when cells were subjected to serum deprivation (Evan et al., 1992) . Thus, while Myc expression provides a mitogenic stimulus, in the absence of Ras or another cooperating oncogene, Myc sensitizes the cell to the apoptotic stress of serum deprivation (Hueber and Evan, 1998) . The eect of Ras and other oncogenes of the signal transduction family is not as clear. Activated Ras leads to cell senescence in the absence of a cooperating oncogene (Serrano et al., 1997) . However, high intensity Ras signaling has been reported to induce apoptosis (Joneson and Bar-Sagi, 1999) , indicating that extreme mitogenic Ras signaling can also activate apoptotic pathways. It has been suggested that Ras and Myc are able to generate a complete mitogenic signal because Myc overrides the cytostatic action of Ras, and Ras generates the survival signals that overcomes the apoptotic signals of Myc (Hueber and Evan, 1998) .
A model for controlling cell proliferation is emerging whereby a mitogenic signal such as Myc or Ras simultaneously activates both mitogenic and apoptotic or senescence pathways. For cell division to proceed, a survival signal(s) must also be generated that suppresses apoptotic signals (Hueber and Evan, 1998) . Signaling through phosphatidylinositol-3-kinase (PI3K) and the downstream kinase Akt has been widely implicated as an important survival signal in cell proliferation (Datta et al., 1997 (Datta et al., , 1999 Kandel and Hay, 1999; Kauman-Zeh et al., 1997; Kennedy et al., 1997) . Interestingly, the activated Src kinase (v-Src) does not induce apoptosis upon serum deprivation (Johnson et al., 2000) , suggesting that v-Src generates both the mitogenic and survival signals necessary for proliferation. Consistent with this hypothesis, apoptosis has been reported in v-Srctransformed cells where downstream signaling components such as Ras and PI3K were blocked (Johnson et al., 2000; Hakak et al., 2000; Webb et al., 2000) .
Activating mutations within the Src gene have been reported in late stage colon cancer (Irby et al., 1999; Irby and Yeatman, 2000) . However, two subsequent studies did not ®nd a correlation between Src mutation and colon cancer (Daigo et al., 1999; Wang et al., 2000) . Thus, activating mutations to Src are apparently rare in human cancer, in spite of the fact that single base pair changes in the carboxy terminus are able to generate an activated Src kinase. This is not true for activating mutations to Ras, which like Src, requires only a single mutation to generate an activated Ras protein. However, activated Ras is not sucient to transform primary cells (Land et al., 1983) and needs another genetic alteration to transform cells. Unlike Src, activating mutations in Ras are seen in approximately 25% of human cancer (Hanahan and Weinberg, 2000) . More common for tyrosine kinases are mutations that lead to increased expression rather than increased activity (Biscardi et al., 1999) . It is not clear why activating mutations for tyrosine kinases are not commonly observed in cancer, but it is likely that cells acquiring a mutation that simultaneously provides both mitogenic and survival signals are eliminated before they can contribute to progression to cancer. Overexpression of a tyrosine is not sucient to transform cells, however cells overexpressing either cSrc or the epidermal growth factor receptor (Hornia et al., 1999) become transformed when protein kinase C d (PKC d) is down regulated. Thus, an initiating mutation, such as an overexpressed tyrosine kinase, in combination with downregulation of PKC d, may be a critical aspect of tumor progression. We report here that while cells partially-transformed by c-Src overexpression become sensitive to apoptotic stress, downregulating PKC d provides an Aktindependent survival signal that overrides apoptotic signals generated in cells overexpressing this tyrosine kinase.
Results
Serum starvation triggers cytochrome c/caspase 9-mediated apoptosis in c-Src-overexpressing 3Y1 cells, but not in parental or v-Src-transformed 3Y1 cells
We demonstrated previously that 3Y1 cells overexpressing c-Src (3Y1 c-Src ) became transformed when depleted of PKC d . However, we noticed that if the 3Y1 c-Src cells were deprived of serum, many of the cells died. This eect was not observed in either the parental or v-Src-transformed 3Y1 cells. Quanti®cation of cell death in the 3Y1 c-Src cells using trypan blue exclusion revealed that approximately 50% of the cells died after 14 h of serum deprivation ( Figure  1a ). This level of cell death is similar to the level of apoptotic cell death reported in rat ®broblasts expressing the Myc oncogene (Evan et al., 1992) . These data indicate that overexpression of c-Src renders cells sensitive to serum withdrawal and that this eect is overcome by the active kinase of v-Src. The lack of cell death observed in the v-Srctransformed cells is consistent with observations by Webb et al. (2000) and Johnson et al. (2000) , who reported that v-Src-transformed cells do not die under conditions of low serum.
Cell death in response to serum deprivation is commonly due to apoptosis (Evan and Littlewood, 1998) . We therefore examined whether the 3Y1 c-Src cells displayed characteristic markers for apoptosis upon serum withdrawal. As shown in Figure 1c Two apoptotic pathways have been described. These two pathways have been characterized as death by design and death by neglect (Green, 1998; Strasser et al., 2000) . Cyochrome c release is always seen in the neglect pathway and frequently in the design pathway (Green, 1998) . Cytochrome c initiates the activation of proteases that begin the apoptotic process (Green, 1998) . We therefore examined the presence of cytochrome c in cytosolic and mitochondrial fractions from the 3Y1 c-Src cells before and after serum deprivation. Upon serum withdrawal, there was a large increase in cytochrome c in the cytosolic fraction and a concomitant reduction of cytochrome c in the mitochondrial fraction (Figure 2a ). Cytochrome c oxidase subunit IV (Cox 4), a mitochondrial protein that is not released to the cytosol during apoptosis, was also monitored by Western blot analysis to con®rm the mitochondrial fractionation procedure.
Apoptosis begins with the activation of initiator caspases ± most commonly caspases 8 and 9. These caspases then proteolytically activate executioner caspases such as caspase 3 (Budihardjo et al., 1999; Strasser et al., 2000) . We examined the activity of caspases 8 and 9 in 3Y1 c-Src cells upon serum withdrawal. A peptide with speci®city for caspases 3, 7 and 10 was used to indicate executioner caspase (primarily caspase 3) activity. As shown in Figure 2b , a large increase in the activity of caspase 3 was detected between 10 and 16 h. This was preceded by an increase in the activity of caspase 9. A small increase in caspase 8 activity was detected, but it was after the increase in caspase 3 (Figure 2b ). Consistent with these data, inhibitory peptides for either caspase 3 or 9, but not caspase 8, prevented the cell death caused by serum deprivation in the 3Y1 c-Src cells ( Figure 2c ). The kinetic data for increased caspase activity are consistent with the time at which cell death and cleavage of death substrates was observed in Figure 1 . The data presented in Figure 2 suggest that the apoptosis induced in 3Y1 c-Src cells by serum withdrawal is initiated by cytochrome c and caspase 9, and executed by caspase 3.
Downregulating PKC d provides a survival signal that overcomes apoptosis in 3Y1 c-Src cells subjected to serum withdrawal
We demonstrated previously that downregulation of PKC d in response to TPA (12-O-tetradecanoylphorbol-13-acetate) transformed the 3Y1 c-Src cells . We therefore examined the eect of PKC d downregulation on cell viability in the 3Y1 c-Src cells subjected to serum withdrawal. As shown in Figure 3 , TPA increased cell viability in the 3Y1 c-Src cells subjected to serum withdrawal. Consistent with an involvement of PKC d, rottlerin, which has been reported to inhibit PKC d in vivo (Gschwendt et al., 1994) , and has been shown to mimic the eects PKC d downregulation in vivo (Lu et al., , 1998 Hornia et al., 1999 ) also increased cell viability in serum starved 3Y1 c-Src cells. In contrast, G 0 6976, which functions as a speci®c inhibitor of PKC a (Lu et al., 1998; Hornia et al., 1999) , had no eect upon cell viability (Figure 3 ). We next examined the eect of PKC d downregulation upon apoptotic phenotypes induced by serum withdrawal in the 3Y1 c-Src and v-Src-transformed cells. As shown in Figure 4a , withdrawal of serum from the 3Y1 c-Src cells resulted in the characteristic 45 kDa PKC d fragment sometimes referred to as PKM (protein kinase M) (Cressman et al., 1995) . As expected, TPA treatment led to the disappearance of PKC d as described previously (Lu et al., , 1998 . c-Src cells were placed in medium either containing (+) or lacking (7) serum for 14 h. The cytosolic (cyto) and mitochondrial (mito) fractions were isolated using ApoAlert Cell Fractionation Kit (CloneTech). The subcellular distribution of cytochrome c (cyto c) was determined by Western blot analysis on cytosolic and mitochondrial fractions. Cox 4 was also monitored by Western blot analysis to con®rm the fractionation. (b) 3Y1 c-Src cells were placed in medium lacking serum for the times indicated. Both adherent and¯oating cells were then collected and subjected to measurement of caspase activity as described in Materials and methods. (c) 3Y1 cells overexpressing c-Src were placed in DMEM containing 10% serum (+) or lacking serum (7) and treated with caspase inhibitors with the speci®cities shown. Cell viability was quanti®ed 14 h later as in Figure 1 However, treatment with rottlerin inhibited the cleavage of PKC d to PKM in the 3Y1 c-Src cells subjected to serum withdrawal (Figure 4a ). Both TPA and rottlerin also inhibited PARP cleavage induced by serum withdrawal in the 3Y1 c-Src cells (Figure 4a ). The PKC a inhibitor G 0 6976 had no eect upon the cleavage of either PKC d or PARP. Cytochrome c release from the mitochondria stimulated by serum withdrawal in the 3Y1 c-Src cells was also inhibited by TPA and rottlerin, but not by G 0 6976 (Figure 4b) . Similarly, TPA treatment prevented the increase in the activity of the executioner caspase 3, 7 and 10 seen in the 3Y1 c-Src cells (Figure 4c ). The data shown in Figures 3 and 4 indicate that downregulating PKC d provides a survival signal that prevents apoptosis in 3Y1 c-Src cells subjected to serum withdrawal. Two recent studies have questioned the speci®city of rottlerin for PKC d (Davies et al., 2000; Solto, 2001) . Therefore, to further establish that the survival signals reported here were in fact due to downregulating PKC d, we examined the eect of a catalytically-inactive PKC d (Hirai et al., 1994) , which we have used previously as a dominant-negative PKC d mutant (Lu et al., , 1998 Hornia et al., 1999) . In Figure 5a , it is shown that transient transfection with the kinasedead PKC d inhibited the proteolytic degradation of both PKC d and PARP in 3Y1
c-Src cells deprived of serum. Note also that as reported previously (Lu et al., 1998) , the kinase dead PKC d is not degraded in response to treatment with TPA (compare the third and ®fth lanes). This observation also con®rms expression of the kinase dead PKC d mutant. The Survival signals provided by TPA are independent of the PI3K/Akt pathway As described above, the v-Src-transformed cells did not undergo apoptosis upon serum withdrawal. This is consistent with reports that cells overexpressing v-Src only undergo apoptosis when part of the signal(s) induced by v-Src are blocked (Johnson et al., 2000; Webb et al., 2000) . In both of these studies, inhibition of PI3K led to apoptosis in v-Src-transformed cells. PI3K mediated survival signals are mediated by the recruitment of Akt, which gets phosphorylated in response to activation (Kandel and Hay, 1999) . We therefore examined whether Akt is phosphorylated in response to the survival signals generated in response to PKC d downregulation. As shown in Figure 6a , TPA treatment did not result in increased Akt phosphorylation. In fact, TPA actually inhibited background Akt phosphorylation in the 3Y1 c-Src cells. Akt phosphorylation could be detected in v-Src-transformed 3Y1 cells and be induced in 3Y1 c-Src cells by a 30 min treatment with serum (Figure 7a ), indicating that the pathway was viable in the 3Y1 c-Src cells. The elevated Akt phosphorylation observed in response to serum and in v-Src-transformed cells was prevented by the PI3K inhibitor LY-294002, indicating that Akt phosphorylation was dependent upon PI3K. We also examined the eect of rottlerin upon Akt phosphorylation and, as shown in Figure 6b , rottlerin did not stimulate Akt phosphorylation. We next examined the eect of LY294002 upon the ability of TPA and rottlerin to prevent PKC d and PARP cleavage. As shown in Figure 6c , LY294002, did not signi®cantly aect the ability of TPA to inhibit PARP cleavage, nor did it aect the ability of rottlerin to prevent either PKC d or PARP cleavage. Lastly, we examined the eect of TPA and rottlerin on cell viability in serum starved 3Y1 c-Src cells in the presence of LY-294002. While LY-294002 reduced cell viability in serum-starved 3Y1 c-Src cells, TPA increased cell survival in the absence or presence of the PI3K inhibitor to approximately the same extent. The eect of rottlerin was even more pronounced, further establishing that the eect of downregulating PKC d goes above and beyond any eects of PI3K. These data indicate that the survival signal generated by PKC d downregulation in the 3Y1 c-Src cells is independent of the PI3K/Akt survival pathway.
Discussion c-Src overexpression cooperates with tumor promoting phorbol esters to transform rat ®broblasts. Thus, c-Src overexpression provides a growth signal that is not sucient to give a fully transformed phenotype. Emerging models for protection against cancer suggest that mitogenic signals also induce apoptotic signals that must be overcome by survival signals in order for cell proliferation to proceed (Hueber and Evan, 1998) . Data presented here indicate that c-Src overexpression sensitizes 3Y1 rat ®broblasts to apoptotic stress and that tumorpromoting phorbol esters provide a survival signal that overrides apoptotic signals generated by c-Src overexpression. Interestingly, v-Src did not sensitize cells to apoptotic stress, indicating that v-Src is able to provide both mitogenic and survival signals. The eect of the catalytically-inactive PKC d and TPA upon cell viability was determined as in Figure 3 Many of the experiments reported here used rottlerin, a compound that has been reported to inhibit PKC d speci®cally (Gschwendt et al 1994) . However, two recent studies (Davies et al., 2000; Solto, 2001) have suggested that rottlerin has little or no eect upon PKC d in vitro. The original study by Gschwendt et al. (1994) , where PKC d was sensitive to 6 mM rottlerin, was performed on PKC d puri®ed from porcine spleen. The systematic study performed by Davies et al. (1999) used PKC d from baculovirus infected insect cells and the study performed by Solto (2001) used PKC d in immunoprecipitates. Therefore, given that PKC d is phosphorylated on many sites, it is possible that PKC d isolated from dierent sources may be dierentially sensitive to rottlerin. We reported previously that activation of PKC was required for ubiquitination and degradation, and that PKC inhibitors prevented ubiquitination and degradation of PKC (Lu et al., 1998) . Importantly, the PKC a inhibitor G 0 6976 prevented ubiquitination and degradation of PKC a, but not PKC d, and reciprocally, rottlerin inhibited ubiquitination and degradation of PKC d, but not PKC a. These data indicated an in vivo speci®city rottlerin for PKC d. Therefore, it is possible that the reported lack of in vitro speci®city for rottlerin on PKC d puri®ed from baculovirus infected insect cells (Davies et al., 2000) or in immunoprecipitates (Solto, 2001) may not re¯ect the apparent in vivo speci®city we have reported previously. As suggested by Solto (2001) , it is possible that the eect of rottlerin in whole cells could be indirect and this warrants further investigation. Whether the eect of rottlerin on PKC d is direct or indirect, rottlerin clearly mimics the eects of both PKC d depletion and dominant negative PKC d in vivo and the data presented here are consistent with the hypothesis that downregulating PKC d overcomes apoptotic signals generated by c-Src overexpression.
It was reported recently that inhibition of both PI3K and Ras resulted in apoptosis in v-Src-transformed rat ®broblasts in the presence of serum (Webb et al., 2000) . In the absence of serum, inhibition of PI3K alone was sucient to cause apoptosis in v-Src-transformed rat ®broblasts (Johnson et al., 2000) . Similarly, in the absence of IL-3, inhibiting Ras signaling induced apoptosis in IL-3-dependent Ba/F3 cells expressing vSrc (Odajima et al., 2000) . Collectively, these data indicate that v-Src activates survival signals mediated by Ras and PI3K. In the absence of survival signals c-Src cells were subjected to serum withdrawal for 14 h in the absence of LY-294002 (50 mM), TPA (400 nM), and rottlerin (15 mM) as shown. Cell viability was determined by trypan blue exclusion as in Figure 1 . The data represent the per cent of cells that excluded trypan blue. Error bars represent the standard error for three samples from a single experiment that was repeated twice provided by serum and growth factors, inhibition of either the PI3K or Ras alone leads to apoptosis. The observation that cells overexpressing c-Src undergo apoptosis in the absence of serum suggests that they are missing the survival signals activated by v-Src. However, downregulation of PKC d was able to activate survival signal(s) sucient to overcome the apoptotic signals primed by c-Src overexpression.
We demonstrated previously that downregulating PKC d transformed cells overexpressing either c-Src or the epidermal growth factor receptor Hornia et al., 1999) . In cells transformed by v-Src, PKC d is phosphorylated on tyrosine, which results in reduced levels of PKC d Blake et al., 1999) . Overexpression of c-Src did not cause any tyrosine phosphorylation of PKC d . Thus, the downregulation of PKC d by v-Src may contribute to the survival of v-Src-transformed cells. Consistent with this notion, the level of PKC d in the v-Src-transformed cells seen in Figure 1c was substantially reduced relative to that seen in the 3Y1 c-Src cells. The emerging paradigm suggests that PKC d may be part of a priming mechanism for apoptotic signaling. In this regard, it is of interest that in response to apoptotic signaling, PKC d is proteolytically cleaved to release the catalytic domain of PKC d. Release of the active catalytic fragment of PKC d may be critical for apoptosis to proceed and therefore downregulating PKC d could be critical for mitogenic signals to be complete.
A pathway for survival signals stimulated by TPA and PKC d downregulation is not yet clear. However since TPA actually inhibited basal Akt phosphorylation, and the PI3K inhibitor LY-294002 had no eect upon the ability of TPA or rottlerin to induce apoptosis, the mechanism does not likely involve the well-established PI3K/Akt survival pathway. Therefore, it is likely that downregulation of PKC d represents a novel survival pathway that is able to overcome the apoptotic phenotype generated in cells with an overexpressed tyrosine kinase.
Materials and methods

Cells, cell culture and transfection conditions
Rat 3Y1 rat ®broblasts, v-Src-transformed 3Y1 cells, and 3Y1 cells overexpressing c-Src were maintained in Dulbecco's modi®ed Eagle medium (DMEM) supplemented with 10% bovine calf serum (HyClone) as described previously . Transient transfection of the 3Y1 c-Src cells with the catalytically-inactive PKC d was performed as described previously (Lu et al., 2000) using lipofectamine reagent (GIBCO) according to the vendors instructions.
Materials
Monoclonal antibody to PARP was obtained from Pharmgen; polyclonal antibody to protein kinase C d (PKC d) was obtained from Santa Cruz Biotechnology; polyclonal antibodies for Akt and phosphorylated Akt were from New England Biolabs. Antibodies to cytochrome c and Cox-4 were from CloneTech as part of the ApoAlert cell fractionation kit. Caspase inhibitors were obtained from BioRad. DAPI (4',6-diamidino-2-phenylindole, dihydrochloride) was obtained from Molecular Probes. LY-294002 was from Calbiochem.
Western analysis
Extraction of proteins from cultured cells was performed as previously described (Lu et al., , 1998 (Lu et al., , 2000 . Equal amounts of protein were subjected to SDS ± PAGE using an 8to 15% acrylamide separating gels, transferred to nitrocellulose and blocked overnight at 48C with 5% non-fat dry milk isotonic phosphate buered saline (PBS: 136 mM NaCl, 2.6 mM KCl, 1.4 mM KH 2 PO 4 , 4.2 mM Na 2 HPO 4 ). The nitrocellulose ®lters were washed three times for 5 min in PBS and then incubated with antibodies as described in the text. Depending upon the origin of the primary antibodies, either anti-mouse or anti-rabbit IgG was used for detection using the ECL system (Amersham).
Apoptosis assays
Trypan blue exclusion was used to quantify apoptosis. After various treatments, cells were harvested with trypsin and washed in PBS. Trypan blue (Sigma) was added to suspended cells at a concentration of 0.4% w/v. After 10 min, trypan blue uptake (dead cells) was determined by counting on a hemocytometer.
DNA fragmentation: DNAzol regent (Gibco ± BRL) was used to extract DNA from 100 mm plates, according to manufacturer's instructions. After RNase treatment, isolated DNA was subjected to 2% agrose gel electrophoresis. The DNA was visualized by ethidium bromide staining under UV light.
DAPI staining: Cells were plated into 8-well chamber slides. After treatments indicated in the text, cells were ®xed in 4% formaldehyde for 15 min at room temperature and permeabilized for 2 min with ice cold methanol. The cells were then blocked with DMEM/10% fetal calf serum for 30 min at room temperature, followed by incubation with DAPI stain (Molecular probe) at 1 mg/ml in PBS for 5 min at room temperature. Nuclei were visualized by¯uorescent microscope.
Caspase assays
Both adherent and suspended cells from cultures were collected and washed with PBS. One hundred ml of lysis buer per 10 7 cells was added with gentle vortex. Samples were subjected to three rounds of freeze and thaw by transferring from an iso-propanol-dry ice bath to 378C water bath. The resultant cell lysates were centrifuged at 48C for 30 min at full speed. Equal amounts of protein were then incubated with caspase-speci®c oligopeptide substrates tagged with the¯uorescent 7-amino-4-tri¯uoromethyl coumarin (AFC) substrate (BIORAD) at 378C for 1 h. Caspase activation was measured by AFC release as detected spectrophotometrically according to the vendor's instructions. Caspase inhibitors were the same peptide substrates tagged with the inhibitory¯uoromethyl ketone (FMK) tag that prevents cleavage by the recognizing caspase.
Subcellular fractionation
Separation of mitochondrial and and cytosolic fractions was performed by using ApoAlert Cell Fractionation Kit (CLON-TECH) according to the manufacturer's speci®cations. Cox 4 antibody (included in the kit) was used to con®rm successful separation of mitochondrial and cytosolic fractions.
